HLA-B 抗体
-
- 抗原 See all HLA-B 抗体
- HLA-B (Major Histocompatibility Complex, Class I, B (HLA-B))
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This HLA-B antibody is un-conjugated
-
应用范围
- Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunoprecipitation (IP), Immunocytochemistry (ICC), Immunohistochemistry (Frozen Sections) (IHC (fro))
- 原理
- Anti-Human HLA-A,B,C Monomorphic Antibody (W6/32)
- 纯化方法
- Protein A or G purified.
- 纯度
- >95 %
- 克隆位点
- W6-32
- 亚型
- IgG2a, kappa
- Top Product
- Discover our top product HLA-B Primary Antibody
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 6 mg/mL
- 缓冲液
- 0.01M PBS, pH 7.4.
- 储存条件
- 4 °C,-20 °C,-80 °C
- 储存方法
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
-
Immunogenic peptides putatively from intratumor microbes: Opportunities for colorectal cancer treatment." in: iScience, Vol. 27, Issue 12, pp. 111338, (2024) (PubMed).
: "
-
Immunogenic peptides putatively from intratumor microbes: Opportunities for colorectal cancer treatment." in: iScience, Vol. 27, Issue 12, pp. 111338, (2024) (PubMed).
-
- 抗原
- HLA-B (Major Histocompatibility Complex, Class I, B (HLA-B))
- 别名
- HLA-B (HLA-B 产品)
- 途径
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
-